Slide background

C3P3® mRNA production system

Eukarÿs is the first company to successfully developing an artificial expression system for the eukaryotes, which opens up novels avenues for synthetic gene therapy – a radically novel and effective therapeutic approach for the treatment of human disorders – as well a broad range of non-therapeutic applications.